Diagnóstico, clasificación y patogenia de la diabetes mellitus
I Conget - Revista española de cardiología, 2002 - Elsevier
Diabetes mellitus (DM) is a metabolic disorder characterized by the presence of chronic
hyperglycemia accompanied by greater or lesser impairment in the metabolism of …
hyperglycemia accompanied by greater or lesser impairment in the metabolism of …
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz… - The Lancet, 2019 - thelancet.com
Background Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce
cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk with high …
cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk with high …
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz… - The Lancet, 2019 - thelancet.com
Background Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal
outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the …
outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the …
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study
E Martinez, A Mocroft, MA García-Viejo… - The Lancet, 2001 - thelancet.com
Background Risk factors for lipodystrophy in patients infected with HIV-1 treated with highly
active antiretroviral therapy (HAART) containing HIV-1 protease inhibitors are poorly …
active antiretroviral therapy (HAART) containing HIV-1 protease inhibitors are poorly …
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
E Fernandez-Egea, M Bernardo, T Donner… - The British journal of …, 2009 - cambridge.org
BackgroundSome studies suggest individuals with schizophrenia have an increased risk of
diabetes prior to antipsychotic use. Small sample sizes and the potential for confounding by …
diabetes prior to antipsychotic use. Small sample sizes and the potential for confounding by …
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial
Y Reznik, O Cohen, R Aronson, I Conget, S Runzis… - The Lancet, 2014 - thelancet.com
Background Many patients with advanced type 2 diabetes do not meet their glycated
haemoglobin targets and randomised controlled studies comparing the efficacy of pump …
haemoglobin targets and randomised controlled studies comparing the efficacy of pump …
Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine
E Martínez, I Conget, L Lozano, R Casamitjana… - Aids, 1999 - journals.lww.com
Objectives: To assess the effects of switching from HIV-1 protease inhibitors (PI) to
nevirapine on metabolic abnormalities in patients with fat redistribution and on CD4 T …
nevirapine on metabolic abnormalities in patients with fat redistribution and on CD4 T …
Design and baseline characteristics of participants in the R esearching cardiovascular E vents with a W eekly IN cretin in D iabetes (REWIND) trial on the …
HC Gerstein, HM Colhoun… - Diabetes, Obesity …, 2018 - Wiley Online Library
The aim was to determine the effects of dulaglutide, a synthetic once‐weekly, injectable
human glucagon‐like peptide 1 analogue that lowers blood glucose, body weight, appetite …
human glucagon‐like peptide 1 analogue that lowers blood glucose, body weight, appetite …
[HTML][HTML] A worldwide survey of activities and practices in clinical islet of Langerhans transplantation
Background: The lack of an international islet transplantation registry has prevented full
visibility of worldwide islet transplantation activity. Methods: A global online survey was …
visibility of worldwide islet transplantation activity. Methods: A global online survey was …
Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management
P Choudhary, BS Olsen, I Conget, JB Welsh… - Diabetes technology …, 2016 - liebertpub.com
Abstract Background: The MiniMed 640G sensor-augmented insulin pump system
(Medtronic, Inc., Northridge, CA) can automatically suspend insulin delivery in advance of …
(Medtronic, Inc., Northridge, CA) can automatically suspend insulin delivery in advance of …